Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News

Pfizer Offloads $3B Stake in Consumer Healthcare Giant Haleon, Reducing Position to 7.3%

by Team Lumida
January 15, 2025
in News
Reading Time: 2 mins read
A A
0
Pfizer’s $43 Billion Gamble: What It Means for Cancer Research

"Pfizer Booth at the CCC 2006 in Vancouver" by colros is licensed under CC BY 2.0

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com
• Sale valued at £2.50B ($3.05B) at 357 pence per share
• Pfizer’s stake reduces from 15% to 7.3%
• Transaction follows GSK’s complete exit in May 2024

What Happened?

Pfizer has executed a major share sale in Haleon, the consumer healthcare company that owns prominent brands like Sensodyne and Advil. The pharmaceutical giant sold 700 million shares at 357 pence each, representing a 2.75% discount to market price. This transaction reduces Pfizer’s ownership from 15% to 7.3% in Haleon, which was created through the 2019 merger of GSK and Pfizer’s consumer healthcare divisions before its 2022 London Stock Exchange listing.

Why It Matters?

This divestment represents a significant shift in Pfizer’s investment strategy and relationship with Haleon. The sale follows GSK’s complete exit in May 2024, suggesting both founding partners are gradually reducing their exposure to the consumer healthcare business. The transaction’s timing and size indicate Pfizer’s potential focus on core pharmaceutical operations and capital reallocation strategies, while also providing substantial liquidity.

What’s Next?

Investors should watch for Pfizer’s deployment of the $3.05 billion in proceeds and any signals regarding its plans for the remaining 7.3% stake in Haleon. The market will also be monitoring Haleon’s performance as an increasingly independent entity, free from its founding partners’ significant influence. The discount offered in this sale might impact Haleon’s short-term share price movements and market perception.

Source
Previous Post

US Population Growth Set to Stall as Deaths Expected to Exceed Births by 2033

Next Post

China’s Central Bank Injects $130.9B in Near-Record Liquidity Move Amid Yuan Support Efforts

Recommended For You

Trump–Xi Truce Trades Rare-Earth Relief for Concessions, Easing Supply-Risk for U.S. Industry

by Team Lumida
7 hours ago
Trump–Xi Truce Trades Rare-Earth Relief for Concessions, Easing Supply-Risk for U.S. Industry

Key Takeaways Powered by lumidawealth.com Trump says Beijing will ease rare-earth export controls, removing a major supply chokepoint for EVs, wind, and defense. Concessions appear reciprocal: tariff relief and...

Read more

Saylor Hikes Preferred Yields to Keep Bitcoin-Funding Engine Running

by Team Lumida
7 hours ago
Saylor Hikes Preferred Yields to Keep Bitcoin-Funding Engine Running

Key Takeaways Powered by lumidawealth.com Strategy Inc. (Michael Saylor) is raising the coupon on its preferred shares—its primary funding vehicle—to revive soft demand. Move signals a higher cost of...

Read more

Fed to Cut Bank Supervision Staff by 30%, Signaling Softer Oversight

by Team Lumida
8 hours ago
Market Watch: Fed Holds Rates, Hints at September Cut”

Key Takeaways Powered by lumidawealth.com Headcount in Supervision & Regulation to drop from ~500 to ~350 by end-2026 via attrition and voluntary separations. Vice Chair for Supervision Michelle Bowman...

Read more

Apple Guides a Big Holiday Quarter on iPhone 17 Upgrades; Services Top $100B

by Team Lumida
8 hours ago
Apple Guides a Big Holiday Quarter on iPhone 17 Upgrades; Services Top $100B

Key Takeaways Powered by lumidawealth.com September-quarter revenue $102.5B (+8% YoY) and shares +~3% after-hours. December-quarter guide: total revenue +10% to +12% YoY, led by double-digit iPhone growth. iPhone revenue...

Read more

Amazon Pops on Q3 Beat as AWS Reacceleration, AI Demand, and Heavy Capex Reassure Street

by Team Lumida
8 hours ago
Amazon Targets Rural America: A Game-Changer for Delivery Services

Key Takeaways Powered by lumidawealth.com Revenue $180B (+13% YoY) and net income $21.2B (+39% YoY); shares +~10% after-hours. AWS grew 20% YoY, fastest since 2022; management says demand outstrips...

Read more

China’s PMI Slips to 49.0: Manufacturing Contraction Deepens Despite Services Stabilizing

by Team Lumida
8 hours ago
China’s Bold Economic Moves: What You Need to Know Now

Key Takeaways Powered by lumidawealth.com Official manufacturing PMI fell to 49.0 in October (Sep: 49.8), seventh straight month below 50. Export orders dropped to 45.9; production slid to 49.7;...

Read more

Trump Leans on Foreign Policy Wins as Domestic Pressures Mount

by Team Lumida
8 hours ago
Trump Tariffs Leave Key Questions on China Supply Chain Rules Unanswered

Key Takeaways Powered by lumidawealth.com Six-day Asia trip yielded trade pledges and investment MOUs; White House touts up to $2T in prospective commitments. Immediate U.S. backdrop: month-long government shutdown,...

Read more

Standard Chartered Lifts 2025 Targets After Profit Beat; Wealth Engine Accelerates

by Team Lumida
1 day ago
Standard Chartered Lifts 2025 Targets After Profit Beat; Wealth Engine Accelerates

Key Takeaways Powered by lumidawealth.com Adjusted pretax profit $1.99B vs $1.79B consensus; shares up ~4% to HK$159.50, a decade high. 2025 income growth guided to upper end of 5–7%;...

Read more

Big Tech’s AI Capex Hits $78B in a Quarter, Testing Market Patience

by Team Lumida
1 day ago
a black square with a blue logo on it

Key Takeaways Powered by lumidawealth.com Alphabet, Meta, and Microsoft spent ~$78B on capex last quarter, +89% YoY, mostly for AI data centers and GPUs. Stocks split: Meta and Microsoft...

Read more

Binance Aid to Trump Family Crypto Preceded CZ Pardon, Supercharging USD1

by Team Lumida
1 day ago
Binance Aid to Trump Family Crypto Preceded CZ Pardon, Supercharging USD1

Key Takeaways Powered by lumidawealth.com Binance helped build World Liberty’s USD1 stablecoin and facilitated a $2 billion USD1-funded stake sale to Emirati investor MGX, lifting USD1’s market cap above...

Read more
Next Post
China’s Bold Economic Moves: What You Need to Know Now

China's Central Bank Injects $130.9B in Near-Record Liquidity Move Amid Yuan Support Efforts

high-rise building during nighttime

NYC's Congestion Pricing Shows Early Success with 8% Traffic Drop, but Businesses Feel the Pinch

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

China’s Financial Overhaul: Xi’s Strategy to Rebalance $9.1 Trillion Debt Crisis

U.S. Deploys Nmesis Missile System in Philippines to Counter China’s Naval Dominance

May 26, 2025
Will September’s Fed Rate Cuts Surprise Investors? Here’s What Deutsche Bank Predicts

Fed Divisions Thrust Powell Into Uncharted Territory

September 17, 2025
Chipotle Profit Falls as Consumers Pull Back

Chipotle Profit Falls as Consumers Pull Back

July 24, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018